Evotec SE (ETR:EVT – Get Free Report)’s share price was down 1.7% on Tuesday . The stock traded as low as €5.84 ($6.41) and last traded at €6.04 ($6.63). Approximately 1,322,658 shares traded hands during trading, a decline of 3% from the average daily volume of 1,360,000 shares. The stock had previously closed at €6.14 ($6.75).
Evotec Stock Performance
The company has a market capitalization of $1.07 billion, a P/E ratio of -6.29, a PEG ratio of 0.98 and a beta of 1.05. The stock’s fifty day moving average price is €6.37 and its 200-day moving average price is €8.94. The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Read More
- Five stocks we like better than Evotec
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Compound Interest and Why It Matters When Investing
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- How to Invest in Blue Chip Stocks
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
